Report Detail

Pharma & Healthcare Global Granisetron Market Size, Status and Forecast 2019-2025

  • RnM3059523
  • |
  • 05 March, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
In 2018, the global Granisetron market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Granisetron status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Granisetron development in United States, Europe and China.

The key players covered in this study
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo

Market segment by Type, the product can be split into
Transdermal system
Injection
Oral

Market segment by Application, split into
Chemotherapy
Post operative

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Granisetron status, future forecast, growth opportunity, key market and key players.
To present the Granisetron development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Granisetron are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Granisetron Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Transdermal system
      • 1.4.3 Injection
      • 1.4.4 Oral
    • 1.5 Market by Application
      • 1.5.1 Global Granisetron Market Share by Application (2014-2025)
      • 1.5.2 Chemotherapy
      • 1.5.3 Post operative
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Granisetron Market Size
    • 2.2 Granisetron Growth Trends by Regions
      • 2.2.1 Granisetron Market Size by Regions (2014-2025)
      • 2.2.2 Granisetron Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Granisetron Market Size by Manufacturers
      • 3.1.1 Global Granisetron Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Granisetron Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Granisetron Market Concentration Ratio (CR5 and HHI)
    • 3.2 Granisetron Key Players Head office and Area Served
    • 3.3 Key Players Granisetron Product/Solution/Service
    • 3.4 Date of Enter into Granisetron Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Granisetron Market Size by Type (2014-2019)
    • 4.2 Global Granisetron Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Granisetron Market Size (2014-2019)
    • 5.2 Granisetron Key Players in United States
    • 5.3 United States Granisetron Market Size by Type
    • 5.4 United States Granisetron Market Size by Application

    6 Europe

    • 6.1 Europe Granisetron Market Size (2014-2019)
    • 6.2 Granisetron Key Players in Europe
    • 6.3 Europe Granisetron Market Size by Type
    • 6.4 Europe Granisetron Market Size by Application

    7 China

    • 7.1 China Granisetron Market Size (2014-2019)
    • 7.2 Granisetron Key Players in China
    • 7.3 China Granisetron Market Size by Type
    • 7.4 China Granisetron Market Size by Application

    8 Japan

    • 8.1 Japan Granisetron Market Size (2014-2019)
    • 8.2 Granisetron Key Players in Japan
    • 8.3 Japan Granisetron Market Size by Type
    • 8.4 Japan Granisetron Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Granisetron Market Size (2014-2019)
    • 9.2 Granisetron Key Players in Southeast Asia
    • 9.3 Southeast Asia Granisetron Market Size by Type
    • 9.4 Southeast Asia Granisetron Market Size by Application

    10 India

    • 10.1 India Granisetron Market Size (2014-2019)
    • 10.2 Granisetron Key Players in India
    • 10.3 India Granisetron Market Size by Type
    • 10.4 India Granisetron Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Granisetron Market Size (2014-2019)
    • 11.2 Granisetron Key Players in Central & South America
    • 11.3 Central & South America Granisetron Market Size by Type
    • 11.4 Central & South America Granisetron Market Size by Application

    12 International Players Profiles

    • 12.1 Kyowa Kirin
      • 12.1.1 Kyowa Kirin Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Granisetron Introduction
      • 12.1.4 Kyowa Kirin Revenue in Granisetron Business (2014-2019)
      • 12.1.5 Kyowa Kirin Recent Development
    • 12.2 Heron Therapeutics
      • 12.2.1 Heron Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Granisetron Introduction
      • 12.2.4 Heron Therapeutics Revenue in Granisetron Business (2014-2019)
      • 12.2.5 Heron Therapeutics Recent Development
    • 12.3 Fresenius Kabi
      • 12.3.1 Fresenius Kabi Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Granisetron Introduction
      • 12.3.4 Fresenius Kabi Revenue in Granisetron Business (2014-2019)
      • 12.3.5 Fresenius Kabi Recent Development
    • 12.4 Hikma Pharmaceuticals
      • 12.4.1 Hikma Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Granisetron Introduction
      • 12.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2014-2019)
      • 12.4.5 Hikma Pharmaceuticals Recent Development
    • 12.5 Teva
      • 12.5.1 Teva Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Granisetron Introduction
      • 12.5.4 Teva Revenue in Granisetron Business (2014-2019)
      • 12.5.5 Teva Recent Development
    • 12.6 Cipla
      • 12.6.1 Cipla Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Granisetron Introduction
      • 12.6.4 Cipla Revenue in Granisetron Business (2014-2019)
      • 12.6.5 Cipla Recent Development
    • 12.7 Sandoz
      • 12.7.1 Sandoz Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Granisetron Introduction
      • 12.7.4 Sandoz Revenue in Granisetron Business (2014-2019)
      • 12.7.5 Sandoz Recent Development
    • 12.8 Wockhardt
      • 12.8.1 Wockhardt Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Granisetron Introduction
      • 12.8.4 Wockhardt Revenue in Granisetron Business (2014-2019)
      • 12.8.5 Wockhardt Recent Development
    • 12.9 Mylan
      • 12.9.1 Mylan Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Granisetron Introduction
      • 12.9.4 Mylan Revenue in Granisetron Business (2014-2019)
      • 12.9.5 Mylan Recent Development
    • 12.10 APOTEX
      • 12.10.1 APOTEX Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Granisetron Introduction
      • 12.10.4 APOTEX Revenue in Granisetron Business (2014-2019)
      • 12.10.5 APOTEX Recent Development
    • 12.11 Dr.Reddy's
    • 12.12 Bluepharma
    • 12.13 Natco Pharma
    • 12.14 Akorn
    • 12.15 Taro Pharmaceutical
    • 12.16 Aurobindo

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Granisetron . Industry analysis & Market Report on Granisetron is a syndicated market report, published as Global Granisetron Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Granisetron market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,077.10
      4,615.65
      6,154.20
      3,588.00
      5,382.00
      7,176.00
      605,163.00
      907,744.50
      1,210,326.00
      325,650.00
      488,475.00
      651,300.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report